Literature DB >> 24623845

Including food 25-hydroxyvitamin D in intake estimates may reduce the discrepancy between dietary and serum measures of vitamin D status.

Christine L Taylor1, Kristine Y Patterson, Janet M Roseland, Stephen A Wise, Joyce M Merkel, Pamela R Pehrsson, Elizabeth A Yetley.   

Abstract

The discrepancy between the commonly used vitamin D status measures-intake and serum 25-hydroxyvitamin D [25(OH)D] concentrations--has been perplexing. Sun exposure increases serum 25(OH)D concentrations and is often used as an explanation for the higher population-based serum concentrations in the face of apparently low vitamin D intake. However, sun exposure may not be the total explanation. 25(OH)D, a metabolite of vitamin D, is known to be present in animal-based foods. It has been measured and reported only sporadically and is not currently factored into U.S. estimates of vitamin D intake. Previously unavailable preliminary USDA data specifying the 25(OH)D content of a subset of foods allowed exploration of the potential change in the reported overall vitamin D content of foods when the presence of 25(OH)D was included. The issue of 25(OH)D potency was addressed, and available commodity intake estimates were used to outline trends in projected vitamin D intake when 25(OH)D in foods was taken into account. Given the data available, there were notable increases in the total vitamin D content of a number of animal-based foods when potency-adjusted 25(OH)D was included, and in turn there was a potentially meaningful increase (1.7-2.9 μg or 15-30% of average requirement) in vitamin D intake estimates. The apparent increase could reduce discrepancies between intake estimates and serum 25(OH)D concentrations. The relevance to dietary interventions is discussed, and the need for continued exploration regarding 25(OH)D measurement is highlighted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24623845      PMCID: PMC3985821          DOI: 10.3945/jn.113.189811

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  25 in total

1.  Estimation of total usual calcium and vitamin D intakes in the United States.

Authors:  Regan L Bailey; Kevin W Dodd; Joseph A Goldman; Jaime J Gahche; Johanna T Dwyer; Alanna J Moshfegh; Christopher T Sempos; Mary Frances Picciano
Journal:  J Nutr       Date:  2010-02-24       Impact factor: 4.798

2.  The distribution and storage of vitamin D and its metabolites in human tissues.

Authors:  E B Mawer; J Backhouse; C A Holman; G A Lumb; S W Stanbury
Journal:  Clin Sci       Date:  1972-09       Impact factor: 6.124

3.  Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use.

Authors:  C J Lewis; N T Crane; D B Wilson; E A Yetley
Journal:  Am J Clin Nutr       Date:  1999-08       Impact factor: 7.045

4.  Calcium absorptive effects of vitamin D and its major metabolites.

Authors:  R P Heaney; M J Barger-Lux; M S Dowell; T C Chen; M F Holick
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

5.  Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry.

Authors:  Hedwig C M Stepman; An Vanderroost; Katleen Van Uytfanghe; Linda M Thienpont
Journal:  Clin Chem       Date:  2011-01-19       Impact factor: 8.327

6.  Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry.

Authors:  Susan S-C Tai; Mary Bedner; Karen W Phinney
Journal:  Anal Chem       Date:  2010-03-01       Impact factor: 6.986

7.  Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men.

Authors:  M J Barger-Lux; R P Heaney; S Dowell; T C Chen; M F Holick
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

8.  Vitamin D: A cholecalciferol metabolite highly active in promoting intestinal calcium transport.

Authors:  J F Myrtle; A W Norman
Journal:  Science       Date:  1971-01-08       Impact factor: 47.728

9.  25-hydroxyvitamin D3 affects vitamin D status similar to vitamin D3 in pigs--but the meat produced has a lower content of vitamin D.

Authors:  Jette Jakobsen; Hanne Maribo; Anette Bysted; Helle M Sommer; Ole Hels
Journal:  Br J Nutr       Date:  2007-05-31       Impact factor: 3.718

10.  Evaluating food fortification options: general principles revisited with folic acid.

Authors:  N T Crane; D B Wilson; D A Cook; C J Lewis; E A Yetley; J I Rader
Journal:  Am J Public Health       Date:  1995-05       Impact factor: 9.308

View more
  19 in total

Review 1.  Evolution of reference materials for the determination of organic nutrients in food and dietary supplements-a critical review.

Authors:  Stephen A Wise; Melissa M Phillips
Journal:  Anal Bioanal Chem       Date:  2018-12-01       Impact factor: 4.142

2.  National Estimates of Serum Total 25-Hydroxyvitamin D and Metabolite Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry in the US Population during 2007-2010.

Authors:  Rosemary L Schleicher; Maya R Sternberg; Anne C Looker; Elizabeth A Yetley; David A Lacher; Christopher T Sempos; Christine L Taylor; Ramon A Durazo-Arvizu; Khin L Maw; Madhulika Chaudhary-Webb; Clifford L Johnson; Christine M Pfeiffer
Journal:  J Nutr       Date:  2016-04-06       Impact factor: 4.798

Review 3.  Best Practices for Dietary Supplement Assessment and Estimation of Total Usual Nutrient Intakes in Population-Level Research and Monitoring.

Authors:  Regan L Bailey; Kevin W Dodd; Jaime J Gahche; Johanna T Dwyer; Alexandra E Cowan; Shinyoung Jun; Heather A Eicher-Miller; Patricia M Guenther; Anindya Bhadra; Paul R Thomas; Nancy Potischman; Raymond J Carroll; Janet A Tooze
Journal:  J Nutr       Date:  2019-02-01       Impact factor: 4.798

4.  Use of Estrogen-Containing Contraception Is Associated With Increased Concentrations of 25-Hydroxy Vitamin D.

Authors:  Quaker E Harmon; David M Umbach; Donna D Baird
Journal:  J Clin Endocrinol Metab       Date:  2016-08-04       Impact factor: 5.958

5.  Compliance with Dietary Guidelines and Increased Fortification Can Double Vitamin D Intake: A Simulation Study.

Authors:  Rajwinder K Harika; Mariska Dötsch-Klerk; Peter L Zock; Ans Eilander
Journal:  Ann Nutr Metab       Date:  2017-01-07       Impact factor: 3.374

Review 6.  25-Hydroxyvitamin D as a Biomarker of Vitamin D Status and Its Modeling to Inform Strategies for Prevention of Vitamin D Deficiency within the Population.

Authors:  Kevin D Cashman; Ellen Ghm van den Heuvel; Ruud Jw Schoemaker; Damien P Prévéraud; Helen M Macdonald; Jayashree Arcot
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

7.  The Emerging Issue of 25-Hydroxyvitamin D in Foods.

Authors:  Christine L Taylor; Janet M Roseland; Paul M Coates; Pamela R Pehrsson
Journal:  J Nutr       Date:  2016-04       Impact factor: 4.798

8.  Prenatal, perinatal, and childhood vitamin D exposure and their association with childhood allergic rhinitis and allergic sensitization.

Authors:  Supinda Bunyavanich; Sheryl L Rifas-Shiman; Thomas A Platts-Mills; Lisa Workman; Joanne E Sordillo; Carlos A Camargo; Matthew W Gillman; Diane R Gold; Augusto A Litonjua
Journal:  J Allergy Clin Immunol       Date:  2016-02-10       Impact factor: 10.793

Review 9.  The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.

Authors:  C M Weaver; C M Gordon; K F Janz; H J Kalkwarf; J M Lappe; R Lewis; M O'Karma; T C Wallace; B S Zemel
Journal:  Osteoporos Int       Date:  2016-02-08       Impact factor: 4.507

10.  Oral 25-Hydroxycholecalciferol Acts as an Agonist in the Duodenum of Mice and as Modeled in Cultured Human HT-29 and Caco2 Cells.

Authors:  Carmen J Reynolds; Nicholas J Koszewski; Ronald L Horst; Donald C Beitz; Jesse P Goff
Journal:  J Nutr       Date:  2020-03-01       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.